8-K: WW International Reports Mixed Q4 Results, Oprah Winfrey to Depart Board
Summary
- WW International reported a 7.1% year-over-year increase in total subscribers to 3.8 million at the end of Q4 2023, driven by digital and clinical subscriptions.
- Q4 2023 revenue was $206 million, a 7.6% decrease compared to the prior year, or 8.7% on a constant currency basis.
- The company's full year 2023 revenue was $889.6 million, a 14.5% decrease year-over-year, or 14.5% on a constant currency basis.
- Adjusted operating income for Q4 2023 was $21.3 million, compared to $23.1 million in the prior year.
- The company reported a net loss of $88.1 million for Q4 2023, compared to a net loss of $35.8 million in the prior year.
- For the full year 2023, the company reported a net loss of $112.3 million, compared to a net loss of $256.9 million in the prior year.
- WW International expects full year 2024 revenue to be between $830 million and $860 million and operating income to be between $100 million and $110 million.
- Oprah Winfrey will not stand for re-election to the board at the 2024 annual meeting, planned for May 9, 2024, and will donate her stock to the National Museum of African American History and Culture.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative. While subscriber growth is positive, the significant revenue decline and net losses are concerning. The departure of Oprah Winfrey from the board adds uncertainty. The company is making strategic shifts, but the financial results are mixed.
Highlights
- WW International's total subscribers increased by 7.1% year-over-year to 3.8 million in Q4 2023.
- Digital subscribers increased by 8.6% year-over-year in Q4 2023.
- Clinical subscribers reached 67,000 by the end of Q4 2023.
- Q4 2023 revenue was $206 million, a decrease of 7.6% year-over-year.
- Full year 2023 revenue was $889.6 million, a decrease of 14.5% year-over-year.
- Adjusted gross margin for Q4 2023 was 61.4%, up from 57.9% in the prior year.
- Adjusted operating income for Q4 2023 was $21.3 million.
- The company expects to end 2024 with 3.8 to 4.0 million subscribers, including 140,000 to 160,000 clinical subscribers.
- Oprah Winfrey will not seek re-election to the board and will donate her shares to the National Museum of African American History and Culture.
- The company anticipates returning to year-over-year growth in subscription revenues in the second half of 2024.
Positives
- The company achieved a 7.1% year-over-year increase in total subscribers, marking the first year-end subscriber growth in three years.
- Digital subscriber numbers increased by 8.6% year-over-year in Q4 2023.
- The company's adjusted gross margin improved to 61.4% in Q4 2023, up from 57.9% in the prior year.
- The company is projecting subscriber growth for 2024, expecting to end the year with 3.8 to 4.0 million subscribers.
- The company anticipates a return to year-over-year growth in subscription revenues in the second half of 2024.
- The company's operating loss decreased significantly from $51.8 million to $6.0 million in Q4 2023.
Negatives
- Q4 2023 revenue decreased by 7.6% year-over-year to $206 million.
- Full year 2023 revenue decreased by 14.5% year-over-year to $889.6 million.
- Product sales and other revenue decreased by 55.1% in Q4 2023 and 44.7% for the full year 2023 due to the wind down of the consumer products business.
- The company reported a net loss of $88.1 million for Q4 2023, compared to a net loss of $35.8 million in the prior year.
- The company reported a net loss of $112.3 million for the full year 2023.
- Workshops + Digital subscribers decreased by 8.3% year-over-year in Q4 2023.
- The company recorded $23.1 million in restructuring charges in Q4 2023, higher than the previously estimated $10 million.
Risks
- The company faces competition from other weight management and health and wellness industry participants.
- There is a risk that the company may fail to retain and grow its subscriber base.
- The company's ability to be a leader in the rapidly evolving clinical weight management market is uncertain.
- The company's strategic initiatives may not be successfully implemented.
- The company is exposed to risks related to a downturn in general economic conditions or consumer confidence.
- The company has a substantial amount of debt and debt service obligations.
- The company's technology or systems may not operate satisfactorily.
- The company is exposed to data security breaches and other malicious acts or privacy concerns.
- The company's international operations are subject to regulatory, economic, political, social, intellectual property, and foreign currency risks.
- The company's exposure to extensive and complex healthcare laws and regulations as a result of the acquisition of Sequence is a risk.
Future Outlook
The company expects full year 2024 revenue to be between $830 million and $860 million and operating income to be between $100 million and $110 million. They also anticipate ending 2024 with 3.8 to 4.0 million subscribers, including 140,000 to 160,000 clinical subscribers and a return to year-over-year growth in subscription revenues in the second half of 2024.
Management Comments
- Sima Sistani, the company's CEO, stated that 2023 was a pivotal year as they began transforming the business for the future and that they returned to year-end subscriber growth for the first time in 3 years.
- Heather Stark, the company's CFO, mentioned that they executed against their 2023 objectives with a return to sign up and subscriber growth, record adjusted gross margin, and improved cost structure.
- Oprah Winfrey stated that she looks forward to continuing to advise and collaborate with WeightWatchers and CEO Sima Sistani in elevating the conversation around recognizing obesity as a chronic condition.
- Thilo Semmelbauer, Chairman of the Board, thanked Oprah Winfrey for her energy, dedication, and for continuing to play a role as collaborator and thought partner going forward.
Industry Context
The announcement reflects the ongoing shift in the weight management industry towards digital and clinical offerings, with WW International focusing on expanding its clinical services and digital subscriptions. The departure of Oprah Winfrey from the board may signal a strategic shift or a move to reduce potential conflicts of interest as the company navigates the evolving landscape of weight loss solutions.
Comparison to Industry Standards
- WW International's subscriber growth, particularly in digital and clinical areas, is a positive sign compared to traditional weight loss programs, but the revenue decline indicates challenges in monetizing these subscribers.
- The company's adjusted gross margin of 61.4% in Q4 2023 is competitive with other subscription-based health and wellness companies, but the overall revenue decline is a concern.
- The shift towards clinical offerings is similar to trends seen in other health and wellness companies, such as Teladoc Health and Hims & Hers Health, which are also expanding into telehealth and clinical services.
- The company's net loss of $112.3 million for the full year 2023 is a significant concern compared to some competitors that have achieved profitability or are closer to breaking even.
- The company's restructuring charges and impairment charges are higher than some competitors, indicating potential challenges in managing costs and assets.
Stakeholder Impact
- Shareholders may be concerned about the revenue decline and net losses, but encouraged by the subscriber growth and future outlook.
- Employees may be affected by the ongoing restructuring and changes in the company's strategy.
- Customers may benefit from the expansion of digital and clinical offerings.
- Suppliers may be impacted by the wind down of the consumer products business.
- Creditors may be concerned about the company's debt and financial performance.
Next Steps
- The company will continue to focus on growing its digital and clinical subscriber base.
- The company will work to improve margins and drive operating income growth.
- The company will host an event on Weight Health in May 2024.
- The company will continue to modernize its technology organization.
Key Dates
- 2015: Oprah Winfrey joined the company's Board of Directors.
- February 26, 2024: Oprah Winfrey notified the Chairman of the Board that she would not be standing for re-election.
- February 28, 2024: WW International issued press releases announcing its financial results and Oprah Winfrey's board transition.
- May 9, 2024: The company's 2024 annual meeting of shareholders is planned to be held.
- March 2024: Oprah Winfrey plans to donate her WW stock to the National Museum of African American History and Culture during the company's upcoming trading window.
Keywords
Filings with Classifications
8-K Filing
- The company received a delisting notice from Nasdaq.
- The company has commenced voluntary prepackaged cases under chapter 11 of title 11 of the United States Code.
- Trading of WW International's common stock is expected to be suspended on May 16, 2025.
Quarterly Report
- The company's financial results were worse than expected due to declining revenues and increasing losses.
- The company's leverage ratio was worse than required by its debt covenants, leading to an expected event of default.
- The company's outlook is worse than expected due to the anticipation of a bankruptcy filing.
Earnings Release
- Overall revenues decreased by 9.7% year-over-year, indicating a decline in the core business.
- Total subscribers decreased by 14.2% year-over-year, suggesting challenges in retaining and attracting customers.
- The company is planning a prepackaged filing under Chapter 11 of the U.S. Bankruptcy Code, indicating financial distress.
8-K Filing
- WW International received a notice from Nasdaq for failing to maintain a minimum share price of $1.00, which is worse than expected.
Annual Results
- The company's revenue decreased by 11.6% compared to the previous year.
- The company recorded a net loss of $345.7 million, a significant increase from the net loss of $112.3 million in the previous year.
- The company's operating loss was $236.2 million, compared to an operating income of $22.3 million in the previous year.
Earnings Release
- Overall subscriber numbers and total revenues decreased in both Q4 and full year 2024.
- Digital and Workshops + Digital businesses experienced declines in subscribers and paid weeks.
- The company reported a significant operating loss for the full year, driven by non-cash impairment charges.
8-K Filing
- The company needed to draw down the remaining amount of its revolving credit facility, which may indicate financial strain.
Quarterly Report
- The company's Q3 2024 results were worse than expected due to a significant net loss, a decline in revenue, and substantial impairment charges.
- The company's net loss for the first nine months of 2024 was significantly worse than the same period in 2023 due to a large impairment charge.
Quarterly Report
- The company's revenue and overall subscriber numbers were down compared to the prior year, indicating worse than expected results.
Quarterly Report
- The company's revenue declined by 10.9% in the second quarter and 12.8% for the first six months of 2024, indicating worse than expected performance.
- The company recorded a significant net loss of $324.6 million for the first six months of 2024, primarily due to a large impairment charge, which is worse than expected.
Quarterly Report
- The company's revenue decreased by 10.9% year-over-year, indicating worse than expected performance.
- The company's net income decreased by 54.2% year-over-year, indicating worse than expected performance.
- The company's total end of period subscribers decreased by 6.1% year-over-year, indicating worse than expected performance.
Amendment to 8-K Filing
- The proposal to adopt a majority voting standard for uncontested director elections was not approved by shareholders, which is a negative outcome for the company's governance structure.
- The initial voting results were erroneous, requiring a correction, which reflects poorly on the company's internal processes.
Quarterly Report Amendment
- The company's net loss of $347.9 million is significantly worse than the $118.7 million loss in the same period last year.
- The company's revenue decreased by 14.6%, indicating a worse performance compared to the prior year.
- The company's operating loss of $269.3 million is significantly worse than the $28.6 million loss in the prior year.
Quarterly Report Amendment
- The company's revenue decreased by 14.6% year-over-year, indicating a worse performance than expected.
- The company reported a significant operating loss of $269.3 million, primarily due to non-cash impairment charges, which is worse than expected.
- The company's total end of period subscribers decreased by 0.5% year-over-year, indicating a worse performance than expected.
Quarterly Report
- The company's net loss of $347.9 million is significantly worse than the $118.7 million loss in the same quarter last year.
- The company's revenue decreased by 14.6%, indicating a decline in business performance.
- The company incurred a $258 million impairment charge on franchise rights, further impacting the financial results.
Quarterly Report
- The company reported a significant operating loss of $269.3 million, primarily due to non-cash impairment charges, which is worse than expected.
- Subscription revenues decreased by 3.7% on a constant currency basis, indicating a decline in core business performance.
- Other revenues declined dramatically by 92.0% on a constant currency basis, which is a significant negative impact.
Regulation FD Disclosure
- The company is on track to exceed its previously provided guidance for clinical subscribers, indicating better than expected performance.
Annual Results
- The company's revenue decreased by 14.5% year-over-year, indicating worse than expected performance.
- The company's gross profit decreased by 14.8% year-over-year, indicating worse than expected performance.
- The company's operating income margin decreased by 4.6% year-over-year, indicating worse than expected performance.
Quarterly Report
- The company's revenue decreased by 7.6% in Q4 2023 and 14.5% for the full year 2023, indicating worse than expected performance.
- The company reported a net loss of $88.1 million in Q4 2023 and $112.3 million for the full year 2023, which is worse than the prior year.
Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.